Research ArticleIMMUNOLOGY

B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes

See allHide authors and affiliations

Science Advances  15 Jan 2021:
Vol. 7, no. 3, eaax3160
DOI: 10.1126/sciadv.aax3160

Article Information

vol. 7 no. 3

PubMed: 
Online ISSN: 
History: 
  • Received for publication May 27, 2020
  • Accepted for publication November 19, 2020
  • .

Author Information

  1. Gihoon You1,*,
  2. Yangsoon Lee2,*,
  3. Yeon-Woo Kang1,
  4. Han Wook Park1,
  5. Kyeongsu Park2,
  6. Hyekang Kim1,
  7. Young-Min Kim1,
  8. Sora Kim1,
  9. Ji-Hae Kim3,
  10. Dain Moon1,
  11. Hyejin Chung2,
  12. Wonjun Son2,
  13. Ui-jung Jung2,
  14. Eunyoung Park2,
  15. Shinai Lee2,
  16. Yong-Gyu Son2,
  17. Jaehyun Eom2,
  18. Jonghwa Won2,
  19. Yunji Park1,
  20. Jaeho Jung2, and
  21. Seung-Woo Lee1,3,
  1. 1Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.
  2. 2ABL Bio Inc., Seongnam, Republic of Korea.
  3. 3Department of Life Sciences, POSTECH, Pohang, Republic of Korea.
  1. Corresponding author. Email: sw_lee{at}postech.ac.kr (S.-W.L.); jaeho.jung{at}ablbio.com (J.J.)
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: January 2021 to August 2021

AbstractFullPdf
Jan 202123340601258
Feb 2021831066495
Mar 202159645316
Apr 202134521233
May 202142620174
Jun 202136527198
Jul 202136455162
Aug 20210175

Stay Connected to Science Advances

Navigate This Article